Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

9 Insider Purchases That Shareholders Should Know About

Insider purchases: There are many insider filings with the SEC on a daily basis, but on the whole, it’s more important to track insider buying activity versus insider selling. In case you’ve missed some of our recent coverage, here’s a recap of the most important insider buys of the week.

Verastem: Director Richard Aldrich bought 1,000 shares at $12.57 each. Shares of Verastem Inc (NASDAQ:VSTM) now trade at $10.77.

Opko Health: CEO, Chairman and all-around permabull Phillip Frost bought 20,000 shares at $11.34 each. Opko Health Inc. (NYSE:OPK) is presently flirting with $11 a share.

Raj Rajaratnam listening to tip

Global Payments: Directors William Jacobs and Gerald Wilkins bought in at $19.35 and $56.74 per share, respectively. Global Payments Inc (NYSE:GPN) now trades just under $57 a share.

Fidelity Southern: Director Rankin Smith bought 691 shares at $14.45 each; the stock is currently priced at $14.66.

Ruby Tuesday: Senior VP Jill Golder purchased 5,000 shares at $6.05; Ruby Tuesday, Inc. (NYSE:RT) now trades five cents higher.

Monmouth: Monmouth R.E. Inv. Corp. (NYSE:MNR) CFO Kevin Miller bought a small amount of shares at $8.47 each; the stock is now at $9.41 per share.

CBIZ: CEO Steven Gerard bought close to 150 shares at $7.41 each; CBIZ, Inc. (NYSE:CBZ) now trades at $7.80.

Symetra Financial: CIO George McKinnon made a small transaction at $15.61 a piece;  Symetra Financial Corporation (NYSE:SYA) is priced at $18.87 as of this writing.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!